Skip to main content
. 2021 Nov 29;16(11):e0260358. doi: 10.1371/journal.pone.0260358

Fig 3. Total effect of cancer on proportion adherent (proportion of days covered > 80%) for anti-hypertensives by cancer site and phase of care.

Fig 3

Point estimates and 95% confidence intervals.